.mw-parser-output .hidden-begin{box-sizing:border-box;width:100%;padding:5px;border:none;font-size:95%}.mw-parser-output .hidden-title{font-weight:bold;line-height:1.6;text-align:left}.mw-parser-output .hidden-content{text-align:left}@media all and (max-width:500px){.mw-parser-output .hidden-begin{width:auto!important;clear:none!important;float:none!important))You can help expand this article with text translated from the corresponding article in French. (May 2020) Click [show] for important translation instructions. Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 6,219 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing French Wikipedia article at [[:fr:Jacques Servier]]; see its history for attribution. You may also add the template ((Translated|fr|Jacques Servier)) to the talk page. For more guidance, see Wikipedia:Translation.
Jacques Servier
Born(1922-02-09)9 February 1922
Died16 April 2014(2014-04-16) (aged 92)
NationalityFrench
Occupation(s)Businessman
Founder of Laboratoires Servier

Jacques Servier (9 February 1922 – 16 April 2014) was a French doctor and businessman. He was the founder and president of Laboratoires Servier, a pharmaceutical company.[1]

Biography

Founder of the pharmaceutical group Servier in 1954, he had a fortune estimated at US$7.7 billion.[2]

The group led by him, Servier, had been convicted several times to pay damages for Mediator, trade name of benfluorex. There was a class action also for Isoméride, trade name of dexfenfluramine. There are also active discussions and trial around benfluorex.[3][4]

Decorations

This section needs additional citations for verification. Please help improve this article by adding citations to reliable sources in this section. Unsourced material may be challenged and removed. (July 2021) (Learn how and when to remove this message)

References

  1. ^ Bloomberg BusinessWeek
  2. ^ "Jacques Servier - Forbes". Forbes. Retrieved 16 April 2014.
  3. ^ "French patients sue over weight-loss drug linked to deaths". The Guardian. 24 November 2010.
  4. ^ Mullard A (March 2011). "Mediator scandal rocks French medical community" (PDF). Lancet. Vol. 377, no. 9769. pp. 890–892. PMID 21409784. Archived from the original (PDF) on 2012-05-25.
  5. ^ "Sarkozy vows health system fix after drug furore". AlertNet. 20 January 2011. Archived from the original on 14 June 2012. Retrieved 24 September 2011.